Multimedia Ad Intelligence
Highest Spending Drug Classes through February 2015
Advertisers in professional health journals spent over $86 million January through February 2015, according to Kantar Media. Cancer Therapy is the top drug class advertising by both dollars and pages, as it was in both 2014 and 2013. These antineoplastic agents make up 11% of the total dollars spent on... Read More
Top Pharma Categories Advertising in Print Medical Journals through February 2015 (by Pages)
Advertisers in professional health journals purchased 13,410 total ad pages through February 2015, according to Kantar Media. Cancer Therapy is the top drug class advertising by both pages and dollars, as it was in both 2013 and 2014. These antineoplastic agents make up over 14% of total share in the market. Top 5 Print... Read More
Top 5 Drugs Advertising in Professional Health Journals through February 2015
Print advertising dollars in professional health journals reached nearly $87 million through February 2015, an 8% decrease year-over-year, according to Kantar Media. Of the top ten products being advertised in professional health journals through February 2015, only three were on the list at this time in 2014. Top 5... Read More
Johnson & Johnson Spent More Than $2.5 Million Advertising in Medical Journals in January 2015
Johnson & Johnson ended 2014 as the top pharma company advertising in medical journals and it's beginning 2015 in the same position. In January, Johnson & Johnson spent about $2.5 million advertising, comprising 6% of the total market share among all companies. Top 5 Print Ad Pharma Companies (Dollars): January 2015 Johns... Read More
Top Pharmaceutical Classes Advertising in Professional Health Journals in January 2015
In the first month of 2015, print advertising dollars in professional health journals reached just over $41 million, a nearly 10% decrease year-over-year, according to Kantar Media. Similar to 2014, Cancer Therapy Products (Antineoplastic Agents) took the top spot as the most advertised product class. The top product... Read More
Top Pharma Classes Advertising in Medical Journals: January 2015
There were 6,319 print advertising pages in medical journals in January 2015, a nearly 10% decrease year-over-year, according to Kantar Media. Antineoplastic agents for cancer therapy is the top drug class advertising by both pages and dollars, as it was in 2014. Further, that product class comprised about 16% of total... Read More
Over $1 Million Spent Advertising Trulicity in Medical Journals in January 2015
It's a new year, which can often mean new pharmaceuticals making big investments advertising in print medical journals. For example, Trulicity—approved in September 2014 for Type 2 Diabetes treatment—has hit the ground running with more than a million dollar print journal ad expenditure. For that investment,... Read More
Which Pharma Companies Spent the Most in Print Journals in 2014?
In 2014, Johnson & Johnson spent more than $34 million advertising its drug products in professional health journals, meaning it comprises 6% of the total market share among all companies. 2014 was Johnson & Johnson's second year in a row as the top spender. Both AstraZeneca and GlaxoSmithKline are new to the top... Read More
The Top Drug Product Classes Advertising in Professional Health Journals in 2014
In 2014, print advertising dollars in professional health journals surpassed $606 million, a 2% increase year-over-year, according to Kantar Media. Antineoplastic Agents took the top spot as the most advertised product class with nearly $52 million spent. The top product classes by dollars are as follows: Top 5 Print Ad... Read More
2014's Most Advertised Drug Class in Medical Journals
There were 95,167 print advertising pages published in medical journals in 2014, a less-than-1% decrease year-over-year, according to Kantar Media. Antineoplastic agents (for cancer therapy) continue to be the top drug class advertising by both pages and dollars, as in both 2012 and 2013. Advertising pages for... Read More
Top Pharmaceuticals in 2014 by Ad Dollars Spent
Invokana, which treats type 2 Diabetes, is once again the top drug product advertised in medical journals by dollars in 2014. For the second year in a row, this product from Janssen Pharmaceuticals comprises about 3% of the total share among all drugs. Antidepressant Brintellix (manufactured by Takeda... Read More
Almost $14 Million Spent Advertising Invokana in Medical Journals Through Q3 2014
Through September 2014, Invokana continues to be the drug product most advertised in medical journals. Invokana, which treats type 2 Diabetes, has spent the most in advertising and purchased the highest number of ad pages, according to Kantar Media. Brintellix, an antidepressant, ranks second by both dollars and pages.... Read More
The Top Drug Product Classes Advertising in Medical Journals Through Q3 2014
There were more than 69,169 ad pages purchased in professional health journals through September 2014, a 2% decrease compared to 2013, according to Kantar Media. At the top of list are cancer therapy products, which continue to be first on the list in terms of pages and dollars. Oral diabetes products are in second... Read More
Cancer Therapy Products are the Top Advertised Drugs in Professional Health Journals through Q3 2014
Print advertising dollars in professional health journals reached more than $443 million through September 2014, a 1% increase year-over-year, according to Kantar Media. The leading product class continues to be Cancer Therapy Products with more than $34 million spent in advertising in print medical journals.... Read More
The Top 5 Pharma Companies Investing in Professional Health Journal Advertising Through Q3 2014
Johnson & Johnson, the top pharma company advertising in professional health journals, more than doubles the second ranked company by dollars invested in advertising through Q3 2014, according to Kantar Media. Johnson & Johnson makes up 6% of the total advertising share, but the company has decreased its spend by 10%... Read More
Johnson & Johnson Making the Biggest Investment in Professional Health Journal Advertising in 2014
Johnson & Johnson, the top pharma company advertising in professional health journals, more than doubles the second ranked company by dollars invested in advertising through August, according to Kantar Media. Johnson & Johnson makes up 7% of the total advertising share, but the company has decreased its spend by 6%... Read More
Invokana & Brintellix are Spending the Most in Print Medical Journal Advertising
Through August 2014, Invokana continues to be the drug product most advertised in medical journals. Invokana, which treats type 2 Diabetes, has spent the most in advertising and purchased the highest number of ad pages, according to Kantar Media. Brintellix, an antidepressant, ranks second by both dollars and pages.... Read More
AdGooroo Finding: Health Insurance is Highly Competitive in Paid Search Advertising
In the latest report from AdGooroo, the firm explored the Health Insurance category and Paid Search advertising, specifically U.S. Google AdWords activity for desktop and tablet on 6,003 health insurance-related keywords in the first half of the year, from January to June 2014. The consistent theme throughout this... Read More
Cancer Therapy Products Dominating the Ad Pages in Medical Journals Through August 2014
There were more than 60,510 ad pages purchased in professional health journals through August 2014, a 1% decrease compared to 2013, according to Kantar Media. At the top of list are cancer therapy products, which continue to be first on the list in terms of pages and dollars. Oral diabetes products are in second... Read More
Cancer Therapy Products are #1 in Professional Health Journal Advertising through August 2014
Print advertising dollars in professional health journals reached more than $389 million through August 2014, a 2% increase year-over-year, according to Kantar Media. The leading product class continues to be Cancer Therapy Products with more than $29 million spent in advertising in print medical journals. This product... Read More